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Differences of the tumour 
cell glycocalyx affect binding 
of capsaicin‑loaded chitosan 
nanocapsules
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The glycocalyx regulates the interaction of mammalian cells with extracellular molecules, such as 
cytokines. However, it is unknown to which extend the glycocalyx of distinct cancer cells control the 
binding and uptake of nanoparticles. In the present study, exome sequencing data of cancer patients 
and analysis of distinct melanoma and bladder cancer cell lines suggested differences in cancer 
cell‑exposed glycocalyx components such as heparan sulphate. Our data indicate that glycocalyx 
differences affected the binding of cationic chitosan nanocapsules (Chi‑NCs). The pronounced 
glycocalyx of bladder cancer cells enhanced the internalisation of nanoencapsulated capsaicin. 
Consequently, capsaicin induced apoptosis in the cancer cells, but not in the less glycosylated benign 
urothelial cells. Moreover, we measured counterion condensation on highly negatively charged 
heparan sulphate chains. Counterion condensation triggered a cooperative binding of Chi‑NCs, 
characterised by a weak binding rate at low Chi‑NC doses and a strongly increased binding rate at high 
Chi‑NC concentrations. Our results indicate that the glycocalyx of tumour cells controls the binding 
and biological activity of nanoparticles. This has to be considered for the design of tumour cell directed 
nanocarriers to improve the delivery of cytotoxic drugs. Differential nanoparticle binding may also be 
useful to discriminate tumour cells from healthy cells.
The glycocalyx is a multifunctional layer of glycans that surrounds all mammalian  cells1,2. This outer glycan 
layer is the interface between cells and the extracellular space, and it controls processes such as intracellular 
signalling, cell adhesion and  endocytosis3. The glycocalyx comprises highly-glycosylated membrane-associated 
proteins including proteoglycans such as syndecans and secreted glycosaminoglycan polymers such as hyaluronic 
 acid1,4. Proteoglycans carry several covalently attached glycosaminoglycan chains such as heparan or chondroitin 
 sulphate3,5. Although glycosaminoglycans are complex molecules with diverse chemical structures, they univer-
sally carry a strong negative charge. Previous studies suggest that the high charge density along polyelectrolyte 
carbohydrate chains such as heparan sulphate is capable of inducing tight counterion binding, which strongly 
screens the negative charge and is known as counterion  condensation6,7.
A growing body of evidence indicates that the glycocalyx of cancer cells differs from that of healthy cells 
because the profile of proteoglycans and glycoproteins is  modified8–11. Also, there might be a higher degree of 
 glycosylation1,12, which appears to be further connected to cancer-related signal  transductions13,14. In this context, 
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the tumour-promoting effect of the glycocalyx has frequently been linked to its ability to bind growth factors 
and  cytokines15. The glycocalyx may also refine the activity of integrins, promoting tumour cell migration and 
interaction with extracellular matrix  components8,16.
Advances in transcriptome and exome sequencing showed that tumour tissues are heterogeneous and com-
posed by distinct populations of tumour cells. Melanoma and bladder cancer belong to the most heterogeneous 
tumour  types17,18. This heterogeneity affects the therapeutic effects of applied drugs and favours the development 
of cancer drug  resistance19. To which extend this cellular heterogeneity is also mirrored by a changed composi-
tion of the glycocalyx is unclear. Recently, a glycosaminoglycan-binding protein from the malaria pathogen 
Plasmodium falciparum was used to target distinct glycans of cancer cells, envisioning that knowledge of the 
cancer cell glycocalyx may improve drug targeted  delivery20,21. Previous studies suggest that the glycocalyx of 
mammalian cells plays a key role in the binding and internalisation of  nanoparticles22–24. However, the impact of 
the potential heterogeneity of the cancer cell glycocalyx on nanoparticle binding and drug delivery is unknown.
The aim of this work was to characterise the glycocalyx structure and density of human cells that originated 
from different tissues and differ in their tumour-progressing phenotype. In further experiments, we aimed to 
correlate the extent of the glycocalyx with its ability to interact with positively charged Chi-NCs. The applied 
Chi-NCs are composed of an oily, lecithin-covered core and a polycationic chitosan  shell25,26. Chitosan is a linear 
polysaccharide consisting of β(1 → 4)-linked units of glucosamine and N-acetylglucosamine, with a degree of 
acetylation usually below 40%, thus appearing as a polycation in aqueous media due to the protonation of the 
glucosamine amine  groups27–29. Chitosan is the main derivative of chitin, a natural structural polysaccharide 
mainly extracted from crustacean shells, cephalopods endoskeleton and fungal cell wall. We considered chitosan 
as a reasonable model compound, as a large number of in vitro and in vivo studies applied chitosan and chitosan-
dependent formulations because of its biodegradability and low  cytotoxicity30–33. The oily core of Miglyol was 
loaded with the lipophilic fluorescent dyes 3,3′-dioctadecyloxacarbocyanine perchlorate (DiO), allowing the 
particles to be tracked and evaluated. We also investigated the ability of capsaicin-loaded Chi-NCs to deliver 
capsaicin and to induce  apoptosis34.
Results and discussion
Characterisation of the glycocalyx of different human cells. Exploration of public exome sequenc-
ing data of bladder cancer and melanoma tissue revealed that genes coding proteoglycans, enzymes of the hep-
aran sulphate or hyaluronic acid biosynthesis and enzymes degrading heparan sulphate or hyaluronic acid are 
frequently mutated or affected by copy number alterations (CNAs). Figure 1 shows that the frequency of somatic 
mutations was higher in melanoma than in bladder cancer. In contrast, CNAs were more frequently detected in 
bladder cancer tissue and less often in melanoma. These data suggest that the glycocalyx of tumour cells of both 
entities is heterogeneous and varies between different patients and most likely even between individual cells 
within the same tumour tissue.
Next, we analysed the glycocalyx of urothelial (T24, UROtsa) and melanoma (BLM, MV3) cells of different 
origin and phenotype. T24 cells are derived from transitional bladder cancer, while UROtsa cells resemble the 
healthy  urothelium35–37. The malignant melanoma cell line BLM has been isolated from lung  metastasis38,39, 
Figure 1.  Genetic alterations in glycocalyx-related genes. (a,b) Screening of public exome sequencing 
data indicate somatic mutations and copy number alterations (CNAs) in tissues of melanoma (mela.) 
and bladder cancer (bladder). (a) Shown are the percentages of patients with genetic alterations in the 
proteoglycans syndecan 1 (SDC1), SDC2, SDC3 and SDC4, the heparan sulphate degrading heparanase (HPSE), 
exostosin glycosyltransferase 1 (EXT1) and EXT2. (b) Shown are the percentages of patients with genetic 
alterations in hyaluronidase 1 (HYAL1) and HYAL2 and hyaluronan synthases (HAS1), HAS2 and HAS3.
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whereas MV3 cells originated from lymph node  metastasis40. Figure 2a shows the analysis of glycocalyx-related 
gene expression by quantitative real time PCR (qRT-PCR). Genes encoding enzymes involved in heparan sul-
phate synthesis, such as exostosin glycosyltransferase 1 (EXT1) and EXT2, were strongly expressed, as were those 
encoding the heparan sulphate proteoglycans syndecan 1 (SDC1) and SDC4. SDC2 was weakly expressed by 
MV3 cells. SDC3 was detected at low levels in T24, and both melanoma cells. In none of the analysed cell lines we 
detected the expressions of hyaluronan synthase 1 (HAS1). HAS2 was weakly expressed by T24, MV3 and BLM 
cells. HAS3 was found in UROtsa cells only. Hyaluronidase 1 (HYAL1) expression was below the detection limit 
in all tested cell lines, while HYAL2 was weakly expressed by T24, MV3 and BLM cells. (Fig. 2a, Supplementary 
Table S1). In summary, qRT-PCR data suggest that in all tested cell lines heparan sulphate is more abundant than 
hyaluronic acid. However, the biosynthesis of glycosaminoglycans is a complex process. For example, heparan 
sulphate biosynthesis involves the action of 11 different enzymes, which cooperate with and antagonise each 
other, thus preventing a straight forward correlation between gene expression levels and the quantity of heparan 
sulphate found on the cell  surface41,42. Therefore, to further characterise the glycocalyx ultrastructure, we applied 
stimulated emission depletion microscopy. Cell surface-exposed glycans were stained by ATTO 646N-conjugated 
wheat germ agglutinin (WGA). We found that the surface morphology was strongly dependent on the origin 
of the cell (Fig. 2b). While the surface of the urothelial cells (UROtsa and T24) was characterised by tube-like 
membrane protrusions (Fig. 2b, white arrow), both melanoma cell lines (BLM and MV3) showed bleb-like bulges 
Figure 2.  Characterisation of the glycocalyx. (a) Analysis of genes involved in heparan sulphate and hyaluronic 
acid biosynthesis in T24 (bladder cancer cells), UROtsa (benign urothelial cells), BLM and MV3 (melanoma 
cell lines) by qRT-PCR, with relative expression levels increasing from blue (not expressed) to red (strongly 
expressed). Measurements were done as multiple PCR runs in triplicates; corresponding data are presented 
in Supplementary Table S1. (b) Stimulated emission depletion microscopy images of the glycocalyx of T24, 
UROtsa, BLM and MV3 showing that the surface morphology was strongly dependent on the origin of the 
cell. T24 and UROtsa cells exposed tube-like cellular protrusions (white arrow), whereas BLM and MV3 cells 
produced bleb-like protrusions (white arrowhead). Scale bars = 1 µm. The shown inserts were placed in dark 
image areas to prevent overlapping of multiple fluorescence signals but to enable the resolution of single glycan 
spots. Glycans were stained by ATTO 646 N-conjugated WGA. (c) Profile of the stimulated emission depletion 
microscope images indicating that the average space between the glycoprotein clusters is approximately 200 nm. 
(d) Schematic drawing of cell membrane bound proteoglycans.
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(Fig. 2b, white arrowhead). The formation of membrane protrusions has been mechanistically linked to the 
density of the mammalian cell  glycocalyx43,44. Therefore, tube-like membrane folding, as found on the urothelial 
cells, may account for a high glycan density. In contrast, bleb-like structures may indicate a low glycan density.
Proteoglycans are organised as clusters on the cell  surface45 in a tuft-like manner with interstitial gaps in the 
hundred-nanometer  range46,47. In line with this concept, we detected single glycoprotein clusters on the surface 
of all cell lines as small dots (Fig. 2b), with an average spacing of ~ 200 nm (Fig. 2c) and a number of approxi-
mately 20 clusters per µm2 (T24: 22 ± 2.9 clusters µm−2; UROtsa: 21 ± 1.4 clusters µm−2; BLM: 18 ± 2.5 clusters 
µm−2; MV3: 18 ± 1.4 clusters µm−2)48. Figure 2d shows a schematic drawing of transmembranous proteoglycans 
and the supposed presentation of glycosaminoglycans at the cellular surface.
Glycocalyx‑dependent binding of Chi‑NCs. The amount of surface-exposed glycans and in particular 
of heparan sulphate was determined by flow cytometry (Fig. 3, Supplementary Fig. S1). The applied WGA rec-
ognises sialic acids and N-acetylglucosamines, which is a principal component of heparan sulphate, hyaluronic 
acid and N- and O-linked glycans. For the detection of heparan sulphate only, we used the specific 10E4 mono-
clonal antibody.
WGA- and 10E4-binding to urothelial cells was of a comparable proportion suggesting that heparan sulphate 
is a major component of the urothelial glycocalyx and that in average T24 cells expose more heparan sulphate 
than UROtsa cells (Fig. 3a). Moreover, UROtsa cells showed a less homogeneous heparan sulphate exposure than 
T24 cells (Supplementary Fig. S1). In melanoma cells (Fig. 3b), we found comparable levels of WGA-binding, 
whereas the 10E4-binding indicates increased levels of heparan sulphate in BLM cells. The surface expression of 
glycan structures was further correlated to the ability of the cells to bind Chi-NCs. The Chi-NCs, schematically 
shown in Fig. 3c, have previously been characterised by our group using dynamic light scattering and trans-
mission electron  microscopy25. We re-evaluated their size and charge by Zetasizer measurements. They had a 
diameter of 157 ± 53 nm, a size polydispersity index of 0.2 ± 0.03 and a ζ-potential of + 49.5 ± 8.1 mV. Nanoparticle 
tracking analysis revealed a comparable diameter of 112 ± 30.2 nm.
Flow cytometry cannot discriminate between surface-bound and intracellular Chi-NCs. Because we aimed 
to measure the ability of the cells to bind Chi-NCs to their surface, we performed our experiments on ice slow-
ing down Chi-NC endocytosis. To verify the cellular localisation of the Chi-NCs, we analysed the cell suspen-
sions by fluorescence and phase-contrast microscopy prior to flow cytometry. Representative images, shown 
in Fig. 3d and e, confirmed that the majority of Chi-NCs were in close proximity to the cell membrane. In our 
quantitative analyses by flow cytometry, we assumed that the cell surface areas of all cells were of an equivalent 
magnitude. T24 cells bound more Chi-NCs than UROtsa cells which correlated with the elevated amounts of 
cell surface-exposed glycans (Fig. 3d). Also BLM cells, which expose more heparan sulphate than MV3 cells, 
bound more Chi-NCs suggesting again the contribution of heparan sulphate in particle binding (Fig. 3e). The 
discrepant binding of WGA and 10E4 to melanoma cells may indicate the presence of further glycans at the cell 
surface. Our qRT-PCR results suggest that in comparison to BLM cells, MV3 cells may carry more hyaluronic 
acid because they express higher levels of HAS2. (Fig. 2a).
Taken together, our data indicate that the tumour cell glycocalyx and especially heparan sulphate contrib-
ute to the binding of Chi-NCs to the surface of the here tested cancer cells. However, it is likely that also other 
glycosaminoglycans such as chondroitin sulphate or heavily glycosylated proteins such as mucins could trap 
cationic nanoparticles at cellular surfaces.
The bladder, and local neoplastic tissues within it, can be accessed by endoscopic surgery, and anti-tumour 
drugs could be administered via catheters to minimise systemic adverse effects. The instillation of nanoparticles 
in defined buffers or media may also improve nanoparticle stability and may prevent unintentional modifications 
such as the formation of protein coronas. The bladder thus appears to be an ideal target for nanotherapeutics. 
Therefore, we focused on the bladder cancer cell line T24 and the urothelial cell line UROtsa in the further 
course of our work.
Internalisation and processing of Chi‑NCs. We loaded Chi-NCs with the model lipophilic cytotoxic 
drug capsaicin, which was previously shown to induce apoptosis in bladder cancer  cells34. Capsaicin is insoluble 
in water, which limits its application as a free drug. Accordingly, we found that the addition of free capsaicin to 
the culture medium of urothelial cells resulted in its precipitation and the generation of crystals (Supplementary 
Fig. S2). In contrast, capsaicin can be loaded efficiently into the o/w emulsion of Chi-NCs due to its partitioning 
between the two  phases25. We have previously shown that the association efficiency of capsaicin was above 90%. 
The release rate of capsaicin from the Chi-NCs in cell culture medium is low and only in the range of 0.3% per 
 hour25.
In the next set of experiments, we applied structured illumination microscopy to measure Chi-NC binding 
and uptake by adherent T24 and UROtsa cells. Representative images are shown in Fig. 4a. After 2 h of Chi-NC 
treatment, most of the Chi-NCs are close to the upper surface of the cells. After 24 h of permanent exposure, 
Chi-NCs appeared to be partially accumulated in perinuclear regions, suggesting Chi-NC uptake via endocytosis 
followed by endosomal  deposition49,50. We further investigated the time-dependent Chi-NC internalisation and 
the potential impact of different capsaicin concentrations (125, 250 and 500 µm capsaicin) on UROtsa and T24 
cells by live-cell fluorescence microscopy (Fig. 4b). Representative videos of cells treated with 250 µm capsaicin 
are shown in Supplementary Video S1 and S2. After 5 and 10 h, cells treated with 250 or 500 µm encapsulated 
capsaicin formed vacuoles in a dose-dependent manner, indicating cellular stress and autophagy due to the 
intracellular engulfment of the cytotoxic  drug51,52. Only few vacuoles were visible in cells treated with 125 µm 
capsaicin. For quantitative analysis, the formation of vacuoles was measured over time (Fig. 4c, Supplementary 
Fig. S3) and the data were fitted to Eq. (1):
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Figure 3.  Expression of glycans and Chi-NC binding capacity of urothelial and melanoma cells. (a,b) 
Comparison of the WGA-binding ability and heparan sulphate expression (10E4-binding) of urothelial cells (a) 
and melanoma cells (b). (c) Schematic illustration of Chi-NCs. (d,e) Urothelial cells (d) and melanoma cells (e) 
were treated with Chi-NCs (1.78 × 1012 particles  mL−1). Prior to flow cytometry, binding of Chi-NCs (green) 
to the cellular surface was verified by fluorescence microscopy (upper panels). Presence of cells was proven by 
phase-contrast microscopy (lower panel). Scale bars = 10 µm. The bar diagram shows the quantitative evaluation 
of flow cytometric results. Data were normalised to the corresponding mean fluorescence of T24 or BLM cells. 
Data are presented as mean ± SD (n = 3–4, *p < 0.05, **p < 0.01).
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where Nv is the number of vacuoles (experimentally measured in the images as an area fraction), Nv,max is the 
maximum detectable number of vacuoles, n is an arbitrary factor, and k−1 is proportionally to the ability of cells 







Figure 4.  Influence of encapsulated capsaicin on T24 and UROtsa cells. (a) Internalisation of fluorescent Chi-
NCs (green) into T24 or UROtsa cells was measured by structured illumination microscopy. Nuclei are stained 
with 4′,6-diamidino-2-phenylindole (blue), cell surfaces (red) were stained with WGA. The upper panel shows 
two-dimensional images of cells treated for 2 or 24 h with Chi-NCs (2.8 × 1012 particles  mL−1). Scale bar = 50 µm. 
The lower panel shows a lateral cross-section of UROtsa cells which has been reconstructed from three-
dimensional image stacks. Scale bars = 5 µm. After 2 h of incubation, Chi-NCs are mainly at the cellular surface; 
after 24 h of incubation, Chi-NCs are underneath the cell surface close to the nucleus (b) Snapshots of live cell 
fluorescence microscopy images of UROtsa and T24 cells treated with different concentrations of capsaicin-
loaded Chi-NCs (1.4 × 1012 particles  mL−1 = 125 µm capsaicin, 2.8 × 1012 particles  mL−1 = 250 µm capsaicin, and 
5.6 × 1012 particles  mL−1 = 500 µm capsaicin) at different points in time (0 h, 5 h and 10 h). Scale bar = 50 µm. 
(c) Quantitative analysis of vacuole formation. Vacuole area is normalized to the number of treated cells. Data 
are presented as mean ± SD (n = 3). (d) Quantitative analysis of the ability of the cells to deposit capsaicin in 
vacuoles (k−1). Data are presented as mean ± SD (n = 3, *p < 0.05). (e) Analysis of cell layer dynamics of T24 (left) 
and UROtsa cells (right) either treated with RPMI-1640 medium (control) or treated with capsaicin-loaded 
Chi-NCs (= Chi-NC-Cap) at a concentration of 500 µm capsaicin (5.6 × 1012 particles  mL−1) and with Chi-NCs 
without capsaicin (5.6 × 1012 particles  mL−1). Data are presented as mean ± SD (n = 3). (f) Snapshots of live cell 
fluorescence microscopy images of T24 cells, 0, 2.5, 5 and 10 min after treatment with DiO-loaded Chi-NCs 
(5.6 × 1012 particles  mL−1) indicating the rapid binding of Chi-NCs to the cell surfaces. Scale bar = 50 µm.
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than in UROtsa cells at a capsaicin concentration of 250 µm. At the highest Chi-NC dose (500 µm capsaicin), T24 
and UROtsa cells formed a comparable number of vacuoles (Supplementary Fig. S3). Moreover, after a prolonged 
incubation time (24 h) and permanent exposure to the capsaicin-loaded Chi-NCs, both cell lines detached from 
the culture flask. This suggests that the high dose of capsaicin was lethal for T24 but also UROtsa cells and that 
the per se reduced Chi-NC internalisation by UROtsa cells was overridden.
Because capsaicin can also promote cell  migration53,54, the dynamic behaviour of the cells was analysed by 
calculating frame-to-frame differences in our videos. In comparison to untreated cells (control), cellular motili-
ties of T24 and UROtsa cells were slightly higher for few minutes after the administration (time point 0 h) of 
Chi-NCs and Chi-NC-Cap (5.6 × 1012 particles  mL−1 = 500 µm capsaicin). After this period of increased cellular 
motility, movement activity of Chi-NC/Chi-NC-Cap treated cells decreases and falls slightly below the control 
level, until it returned to normal. Of note, changes of the cell layer dynamics appeared to be capsaicin independ-
ent because capsaicin-free and capsaicin-loaded Chi-NCs showed a comparable effect. This is also in line with the 
low release rate of capsaicin from the Chi-NCs suggesting only minor levels of free drug, which are insufficient 
to induce cell migration (5.6 × 1012 particles  mL−1 = 500 µm capsaicin, Fig. 4e). Live fluorescence microscopy 
showed that the Chi-NCs bound rapidly to the cells (Fig. 4f) and that Chi-NC binding was also associated with 
cellular detachment, which may coincide with the initially increased cellular motility (Supplementary Video S3).
In summary, our results suggest that Chi-NCs efficiently deliver capsaicin into urothelial cells and that the 
cytotoxic response is most likely dependent on intracellular vacuole formation.
Capsaicin‑induced cytotoxicity. To confirm the fluorescence microscopy data, we used electrical cell-
substrate impedance sensing (ECIS) for real-time quantification of cell  behaviour55. ECIS or similar methods 
have frequently been used to measure the loosening of cell–cell  contacts56. We applied ECIS to measure Chi-
NC binding to the cell surface and the formation of vacuoles upon particle endocytosis. To enable a reliable 
data interpretation, we cultivated T24 and UROtsa cells until they formed a confluent cell layer prior to the 
treatment with Chi-NCs. Representative microscopic images of cultivated cells are shown in Supplementary 
Fig. S4a. Absolute impedance of both cell lines was of a comparable magnitude before treatment (Supplementary 
Fig. S4b). The measured electrical impedance of both urothelial cell lines decreased rapidly after treatment with 
500 µm nanoencapsulated capsaicin pointing towards an early cell detachment due to cytotoxicity, preventing 
reasonable data interpretation (Supplementary Fig.  S4c and d). Therefore, we excluded those data from our 
analysis. After treatment with 125 and 250 µm encapsulated capsaicin or equivalent amounts of empty Chi-NCs 
(1.4 × 1012, 2.8 × 1012) particles  mL−1), we observed an increase in impedance which most likely reflects the bind-
ing of Chi-NCs to the cell surface (Fig. 5a,b). This initial increase of impedance peaked after 30 min and then 
underwent exponential decay. The latter observation may reflect the clearance of Chi-NCs from the cell surface 
by endocytosis which subsequently resulted in vacuole  formation57. The response was more pronounced in T24 
cells than in UROtsa cells at both Chi-NC concentrations, agreeing with the higher Chi-NC binding and vacu-
ole formation capacity of T24 cells. In principle, ECIS is also sensitive to cell migration which may also account 
for changes in the measured  impedance58. However, we consider this effect in our experiment as less relevant, 
because our microscopic analysis, shown in Fig. 4e, suggested that Chi-NCs affected the migratory potential of 
urothelial cells only slightly.
We assume that the time-dependent change in the impedance Z reflects the number of surface bound Chi-
NCs and the formation of vacuoles. Accordingly, we correlated the measured Z to the binding of Chi-NCs and 
to the number of formed vacuoles as shown in Eq. (2):
where Z0 is the normalised impedance before Chi-NC treatment (t = 0 h), Zmax is the maximum detectable 
impedance, a−1 is a factor proportional to the binding of Chi-NCs, and Nv is the number of vacuoles from Eq. (1). 
Representative fitting of our impedance data is shown in Supplementary Fig. S5.
To facilitate better comparison with our flow cytometry and microscopy data, we segregated the fitted results 
and plotted the supposed Chi-NC binding and Nv against time (Fig. 5c,d). In addition, Fig. 5e shows factor a−1 
as a measure for Chi-NC binding. The ability of cells to deposit capsaicin in vacuoles (k−1) is shown in Fig. 5f. 
T24 cells bound significantly more Chi-NCs than UROtsa cells. Moreover, and in good agreement with our 
microscopic analysis shown in Fig. 4d, ECIS indicated that T24 cells formed more vacuoles than UROtsa cells 
(Fig. 5f). This in turn suggests that more capsaicin has been delivered to the T24 cells. No vacuole formation 
was detected at 125 µm capsaicin because the data fit did not converge to a reasonable result (Supplementary 
Fig. S6). WST-1 assays confirmed a reduced cell viability of T24 cells which were treated with 250 µm encap-
sulated capsaicin (Fig. 5g). In comparison, UROtsa cell were only slightly affected. In further experiments, we 
confirmed the induction of apoptosis by probing western blots of cell lysates for the apoptotic marker cleaved 
caspase-3 (Fig. 5h and Supplementary Fig. S7). In the presence of 250 µm encapsulated capsaicin, the level of 
cleaved caspase-3 increased strongly in T24 cells but remained close to the detection level in UROtsa cells. Pro-
longed exposure of the western blot membrane revealed low levels of cleaved caspase-3 in UROtsa cell treated 
with 250 µm encapsulated capsaicin (Supplementary Fig. S8). There was no reasonable caspase-3 cleavage in 
either cell line in response to 125 µm encapsulated capsaicin.
Our data suggest that the enhanced binding of Chi-NCs to T24 cells supports the cytotoxic action of capsaicin, 
whereas the viability of UROtsa cells was not strongly affected upon Chi-NC binding. We cannot exclude that 
other cellular mechanisms such as the intracellular processing of capsaicin or the Chi-NCs may account for the 
measured effects. However, our data illustrate that glycocalyx-dependent differences in nanoparticle binding 
and internalisation may also affect the biological activities of nanoencapsulated drugs. Our results indicate that 
T24 cells, in comparison to UROtsa cells, exhibit a pronounced and aberrant glycosylation which increased 
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Figure 5.  Impedance measurements of T24 and UROtsa cells following treatment with capsaicin-loaded 
or empty Chi-NCs. (a) Control experiments with empty Chi-NCs (no capsaicin) at indicated nanoparticle 
concentrations (2.8 × 1012 and 1.4 × 1012 particles  mL−1). Data are presented as mean ± SD (n = 4). (b) Treatment 
with capsaicin-loaded Chi-NCs (Chi-NC-Cap) at indicated concentrations (2.8 × 1012 particles  mL−1 = 250 µm 
capsaicin, and 1.4 × 1012 particles  mL−1 = 125 µm capsaicin). The response of T24 cells was more pronounced 
than that of UROtsa cells. Data are presented as mean ± SD (n = 4). (c) Binding of Chi-NC-Cap as a function 
of time (2.8 × 1012 particles  mL−1 = 250 µm capsaicin). Data are presented as mean ± SD (n = 3). (d) Vacuole 
formation as a function of time upon treatment with Chi-NC-Cap (2.8 × 1012 particles  mL−1 = 250 µm capsaicin). 
Data are presented as mean ± SD (n = 3). (e) Derived from (c), ability of cells to bind Chi-NC-Cap (a−1). Data 
are presented as mean ± SD (n = 3, **p < 0.01). (f) Derived from (d), ability of T24 and UROtsa cells to deposit 
capsaicin in vacuoles (k−1). Data are presented as mean ± SD (n = 3, *p < 0.05). (g) Viability of Chi-NC-Cap 
treated T24 and UROtsa cells (2.8 × 1012 particles  mL-1 = 250 µm capsaicin, and 1.4 × 1012 particles  mL−1 = 125 µm 
capsaicin) was measured by WST-1 assay. RPMI-1640 medium (control) and 1% v/v Triton-X 100 were used as 
reference. Data are presented as mean ± SD (n = 3, *p < 0.05) (h) Detection of procaspase-3, cleaved caspase-3 
and α-tubulin by western blot in lysates of cells treated with Chi-NC-Cap (1.4 × 1012 particles  mL−1 = 125 µm 
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their susceptibility to nanoparticle-delivered drugs. Previous studies proposed that the ability of cancer cells to 
metastasize is enhanced by an extended  glycocalyx8. This implicates that malignant cells were stronger glyco-
sylated than benign cells. However, it appears that this cannot be generalized to every cell line or tumour entity. In 
melanoma, Cherfils-Vicini et al. showed that reduced heparan sulphate levels promote lung metastasis suggesting 
that malignant cells are less  glycosylated59. In our own previous work, we showed that elevated heparan sulphate 
levels on melanoma cells reduce their ability to metastasize into the lung, whereas the formation of lymph node 
metastasis was  promoted15. In bladder cancer, an altered expression and composition of glycosaminoglycans such 
as the oncofoetal chondroitin sulphate has been  reported21. Taken together these data indicate that the glycocalyx 
of cancer cells can be altered regarding expression levels and structure. This also implicates an altered capability 
of cancer cells to interact with nanoparticles compared with benign cells. However whether cancer cells have an 
increased or decreased capacity to bind nanoparticles might depend on the tumour entity and in particular on 
tumour cell specific features. Therefore, detailed knowledge of the cancer cell glycocalyx is required to optimize 
the therapeutic application of nanoencapsulated drugs.
To further characterise the contribution of the glycocalyx to Chi-NC binding and to better understand its 
molecular basis we analysed the interaction between Chi-NCs and the urothelial cell lines in more detail.
Cell‑specific glycocalyx tunes the electrostatic interaction with Chi‑NCs. Our data shown in 
Fig. 3 suggest that heparan sulphate is involved in the Chi-NC binding to urothelial cells. To further under-
line the expected action of electrostatic  forces60, we measured the charge density (ζ-potential) on urothelial cell 
surfaces. In line with their higher Chi-NC binding ability, T24 cells are significantly more negatively charged 
than UROtsa cells (Fig. 6a). Moreover, reduced cellular binding of negatively charged nanoemulsions (diam-
eter = 135 ± 28 nm, ζ-potential = − 31.4 ± 4.83 mV, Fig. 6b25,26) further confirmed that the interaction between 
Chi-NCs and the urothelial cells is driven by electrostatic forces (Fig. 6b). Electrostatic interactions have often 
been exploited for the intracellular delivery of drugs and nucleic acids through different polycationic nanocar-
rier  systems61–63.
Seiler and  colleges21 showed that chondroitin sulphate is a valid therapeutic target on bladder cancer cells. 
Because chondroitin sulphate is, similar to heparan sulphate, highly negatively charged, it may also contribute 
to the binding of Chi-NCs to bladder cancer cells. Therefore, to further clarify the contribution of glycocalyx 
components such as heparan sulphate, chondroitin sulphate and hyaluronic acid, we treated T24 and UROtsa 
cells with heparinase, chondroitinase and hyaluronidase (Fig. 6c,d). In case of T24 cells, hyaluronidase and 
chondroitinase treatment had little effect on Chi-NC binding, whereas elimination of heparan sulphate by hepa-
rinase prevented Chi-NC binding efficiently. Interestingly, Chi-NC binding to UROtsa cells appeared to be more 
complex and dependent on hyaluronic acid, heparan and chondroitin sulphate. However, it is worth mentioning 
that the applied chondroitinase may also exhibit slight activity on hyaluronic  acid64. UROtsa cells express also 
more heparanase (HPSE) than T24 cells (Fig. 2a). Accordingly, the intrinsic HPSE of UROtsa cells can partially 
remove heparan sulphate from the cellular surface also during chondroitinase or hyaluronidase treatment.
Heparan sulphate related counterion condensation affects Chi‑NC binding. It is known from 
polymer science that the mobility of counterions, and thus their charge screening effect, depends on the charge 
density of the proximate polyelectrolyte. Previous data suggest a strong charge screening effect along heparan 
sulphate chains through counterion  condensation6. Whereas high counterion mobility and moderate charge 
screening occurs in polyelectrolytes with low charge densities, the counterion mobility approaches zero (coun-
terion condensation) for highly-charged polyelectrolytes, resulting in strong charge screening. We assume that 
counterion condensation may also influence the electrostatic interaction between oppositely charged mamma-
Figure 6.  Electrostatic properties of urothelial cells. (a) Cell surface charge measurements of T24 and UROtsa 
cells. Data are presented as mean ± SD (n = 3, *p < 0.05). (b) Schematic composition of the nanoemulsion 
(NE) and NE-binding capacity of T24 and UROtsa cells. NE and Chi-NC concentration = 1.78 × 1012 particles 
 mL−1. Data are presented as mean ± SD (n = 3–4, **p < 0.01) and shown in relation to the Chi-NC binding 
capacity. (c,d) Chi-NC binding of T24 (c) and UROtsa cells (d) after digestion of the cellular glycocalyx with 
chondroitinase, hyaluronidase or heparinase. Chi-NC concentration = 8.96 × 1011 particles  mL−1. Bovine serum 
albumin (BSA) treated cells were used as controls. Data are presented as mean ± SD (n = 3, **p < 0.01).
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lian cells and nanoparticles. Counterion condensation may even create a counterintuitive effect, in which cells 
with high levels of heparan sulphate show weak nanoparticle binding. In contrast, cells with less heparan sul-
phate may have an increased ability to interact with nanoparticles. The counterion condensation  theory7 postu-
lates that the dimensionless line charge density ξ is a decisive parameter for counterion condensation.
The value of ξ is defined as shown in Eq. (3):
where b is the average distance between charges along the polyelectrolyte chain, e is the elementary charge, ε0 is 
the vacuum permittivity, ε is the dielectric constant of the solvent (78.5 for water at 25 °C), k is the Boltzmann’s 
constant, and T is the absolute temperature. The value of b is calculated as shown in Eq. (4):
where L is the contour length of the polyelectrolyte and P is the number of charged groups.
The counterion condensation theory predicts that condensation occurs when ξ > 1. Heparan sulphate can carry 
up to four charges per nanometre, which based on Eqs. (3) and (4) gives b = 0.25 nm and ξ = 2.9, supporting the 
occurrence of counterion condensation. Comparable electrostatic properties could be supposed for chondroitin 
sulphate. Hyaluronic acid is less negatively charged and most likely not affected by counterion  condensation65.
In our preceding experiments, we applied high saturating Chi-NC concentrations. Therefore, we expect 
that the Chi-NC binding was mainly controlled by the total number of available binding sites at the cell surface 
(Fig. 3). In addition, high concentrations of Chi-NCs ensured also that sufficient capsaicin was delivered into the 
cells to induce apoptosis (Fig. 5). To analyse the potential impact of charge screening on the binding of Chi-NCs 
to mammalian cells, we treated both urothelial cell lines with different and lower concentrations of Chi-NCs 
(1.12 × 1011 to 1.78 × 1012 particles  mL−1). Figure 7a shows the dose-dependent Chi-NC binding to UROtsa and 
T24 cells. To prevent misinterpretations due to the differences in Chi-NC binding capacity of T24 and UROtsa 
cells (Fig. 3d), we normalised the maximal measured mean fluorescence of T24 and also of UROtsa cells to 
100%. At low Chi-NC concentrations and thus below saturation and independent of other limiting factors, such 
as differences in cell size, particle binding increases linearly with increasing amounts of Chi-NCs. However, the 
dose-dependent increment of particle binding was 2.5 times steeper in the UROtsa cell group than in the T24 
cell group (UROtsa: 17.0 × 10–11 (%(Chi-NC binding) ml  n−1); T24: 6.6 × 10–11 (%(Chi-NC binding) ml  n−1)). 
Moreover, the binding curve of the T24 cells suggests a cooperative binding behaviour, with a weak binding rate 
at low Chi-NC doses and an increasing rate towards higher Chi-NC concentrations before saturation is reached. 
Following the idea of counterion condensation, the weak interaction between T24 cells and Chi-NCs at low doses 
may reflect the screening of negative charges on the heparan sulphate chains by counterions, which results in 
less potential binding sites for Chi-NCs.
Recently, counterion condensation on heparin was shown to increase with the heparin chain length, also sug-
gesting an increase in counterion condensation on cells with high levels of heparan sulphate, such as T24  cells6. 
Interestingly and in contrast to T24 cells, Fig. 6b indicated that Chi-NC binding to UROtsa cells was at least 
partially dependent on hyaluronic acid which is not sufficiently charged to provoke counterion  condensation65. 
This may also explain the non-cooperative binding of Chi-NCs to UROtsa cells (Fig. 7a). In further experiments, 
we analysed Chi-NC binding in a salt-free sucrose buffer, anticipating the promotion of electrostatic interac-
tions and the abolishment of the counterion condensation effect (Figure S9). Indeed, under these conditions, the 
cooperative binding of Chi-NCs to T24 cells was attenuated indicating less counterion condensation. Because 
the absence of salt is stressful for mammalian cells, we aimed to confirm the impact of the supposed counte-
rion condensation by additional experiments. Accordingly, we repeated our flow cytometry experiments with 
T24 cells treated with heparinase. We assumed that a thinner glycocalyx with shorter heparan sulphate chains 
exhibit less counterion condensation and in turn an improved Chi-NC binding at low particle doses. Although 
the cooperativity of the cell-particle interaction was not completely abolished, normalised particle binding rate 
to T24 cells with chopped heparan sulphate chains was increased in comparison to control T24 cells (Fig. 7b). 
Further in silico modelling of our data enabled us to estimate the initial effective charge, occurring at the cel-
lular surface prior to the addition of Chi-NCs (Fig. 7b, dashed lines). Our model assumed a reduced number 
of binding sites for Chi-NCs below a critical nanoparticle concentration due to counterion condensation. The 
related decreased probability of binding events attenuated the number of cell-bound particles. Above the critical 
Chi-NC concentration, the release of tightly bound counterions increased the number of binding sites and thus 
the probability of binding events. We further translated the assumed initial effective charge to a corresponding 
initial charge density (ξ0) as previously  reported6. Accordingly, the calculated ξ0 value of the control T24 was 4.2, 
thus indicating strong counterion condensation, whereas upon heparinase-treatment ξ0 was assumed to be 1.5, 
suggesting only weak condensation. Moreover, our data enabled us to determine the critical amount of Chi-NCs, 
c*, required for the transition from the condensation regime at low particle concentrations to non-compromised 
counterion mobility at higher Chi-NC doses (Fig. 7b). For transition in the control T24 cells, 2.6 × 1011 Chi-NCs 
 ml−1 were required; whereas in T24 cells that underwent heparan sulphate degradation the transition occurred 
already at c* = 1.2 × 1011 Chi-NCs  ml−1. In summary, we postulate that the interaction between mammalian cells 
with an extended glycocalyx and cationic nanoparticles is diminished at low doses (Fig. 7c, left), while disruption 
of the counterion condensation regime above a critical amount of nanoparticles releases screened binding sites 
at the cellular surface which promotes further nanoparticle binding (Fig. 7c, right). By determine c*, we were 
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heparinase-treated T24 cells, respectively (Supplementary Information). This agrees with the previously measured 
glycocalyx thickness of mammalian  cells8,59.
The theory of counterion condensation is applicable to several polyions but may not completely describe the 
effects we measured at the cellular  surface66. Detailed molecular dynamics simulations may offer an interesting 
way to understand better the occurrence and relevance of counterion condensation at the glycocalyx of mam-
malian  cells67.
Figure 7.  Dose-dependent binding of fluorescent Chi-NCs to T24 and UROtsa cells. (a) Chi-NC binding of 
T24 and UROtsa cells at increasing Chi-NC concentrations (1.12 × 1011 to 1.78 × 1012 particles  mL−1) measured 
by flow cytometry. Data are presented as mean ± SD (n = 4). Because UROtsa cells bound significantly less 
Chi-NCs than T24 cells (Fig. 3d), we normalised the maximum of detectable fluorescence of both cells to 
100%. Dashes lines indicate the initial dose-dependent increment of the measured fluorescence. (b) Chi-NC 
binding to control (red circles) or heparinase-treated (blue circles) T24 cells. The grey dashed line indicates in 
silico simulations of Chi-NC binding to cell surfaces in the absence of counterion condensation (initial charge 
density (ξ0) < 1), the blue dashed line shows simulation of Chi-NC binding at ξ0 = 1.5 suggesting weak counterion 
condensation and the red dashed line shows simulation of Chi-NC binding at ξ0 = 4.2, representing strong 
counterion condensation. Chi-NC concentrations = 4.97 × 1010 to 1.27 × 1012 particles  mL−1). (c) Schematic 
illustration of the proposed counterion condensation effect regulating Chi-NC binding to the negatively charged 
heparan sulphate chains. Prior to the treatment with Chi-NCs, counterions are tightly bound to the heparan 
sulphate chains due to counterion condensation (left). The initial charge density (ξ0 > 1) results in the strong 
screening of negative charges by counterions, which lowers the effective charge. Cooperative binding of Chi-
NCs to heparan sulphate neutralises some of the negative charges leading to a reduced charge density (ξ < 1), 
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Conclusion
In the past, the glycocalyx of mammalian cells has been investigated extensively to determine its role in cell 
migration and the perception of extracellular signals, but knowledge on its role for the interaction of cells with 
nanoparticles is scarce. In line with the public databases, our results suggest that the glycocalyx of different 
tumour cells of distinct entities are highly heterogeneous, which appear to be further translated to different 
nanoparticle binding capacities. However, we found that particle binding and the composition as well as the 
extent of the glycocalyx are not related in a simple manner. The contribution of different glycocalyx components 
and charge screening effects through counterion condensation must be taken into account. This work focused 
on the urothelial glycocalyx because the bladder is a hollow organ amenable for direct and local administration 
of nanoparticles, thus circumventing the limitations of systemic delivery such as the formation of a protein 
corona and nanoparticle clearance. However, the crosstalk between the glycocalyx and nanoparticles appears 
to be a common feature affecting the interactions between nanoparticles and all cancer cells. Here, we present 
a quantitative approach that enables to estimate the critical number of nanoparticles needed to maximise their 
binding to the glycocalyx of urothelial cells, thus promoting a localised drug delivery. This knowledge may be 
realised in future applications aiming to the rational dosage of nanoparticles for therapy or imaging purposes. 
Advanced knowledge of the acting electrostatic forces appears to be required to improve nanoparticle-mediated 
drug targeting and to prevent the generation of drug resistances during therapy.
Methods
Additional methods are described in the supplemental methods section (Supplementary Information).
Cell culture. The human bladder cancer cell line T24 (derived from urinary bladder  carcinoma68,69), the 
benign immortalised urothelial UROtsa cell line (kindly provided by Dr. Phillip Erben, Heidelberg Univer-
sity; derived from the urothelium lining the ureter of a 12-year-old  girl35–37,70) as well as the human metastatic 
melanoma cell lines MV3 (developed from lymph node  metastases40), and BLM (subline of BRO, derived from 
a primary human melanoma, isolated from lung metastasis after subcutaneous inoculation of nude mice with 
BRO  cells38,39) were cultured in RPMI-1640 medium (Sigma-Aldrich, Darmstadt, Germany) supplemented with 
10% fetal bovine serum (FBS), 1% l-glutamine (Biochrom, Berlin, Germany) and 1% penicillin/streptomycin 
(Biochrom) as described  previously71. The cells were incubated in a humid atmosphere at 37 °C with a 5%  CO2 
atmosphere until they achieved a confluency of 90%.
Preparation and characterisation of nanoformulations. Chi-NCs were prepared according to the 
solvent displacement  technique61 with  modifications26. Briefly, an organic phase was formed by dissolving 
40 mg of lecithin (Cargill, Krefeld, Germany) in 1 mL of ethanol, followed by the addition of 530 µL capsaicin 
solution (Sigma-Aldrich; 96% pure dissolved in ethanol to 24 mg mL−1), 125 μL Miglyol 812 (Peter Cremer 
Oleo, Hamburg, Germany), and the lipophilic dye DiO (Santa Cruz Biotechnology, Heidelberg, Germany) to 
obtain capsaicin concentration of 10 mM and dye concentrations of 0.158 mM, in the final formulation after 
 evaporation25. Unloaded Chi-NCs were prepared by replacing the capsaicin solution with ethanol. The organic 
phase was made up to 10 mL with ethanol and then immediately poured over 20 mL of an aqueous chitosan solu-
tion (0.5 mg mL−1 dissolved in water with a 5% stoichiometric excess of 1 M HCl) containing chitosan HMC 70/5 
with a degree of acetylation of 32% (as determined by 1H NMR) and a molecular weight of 5.01 × 104 g mol−1 
(Heppe Medical Chitosan, Halle, Germany), the same material as in our previous  studies26. The Chi-NCs formed 
spontaneously due to solvent displacement and Marangoni  effects72. Finally, the ethanol and part of the water 
were evaporated at 40 °C under vacuum in a R210 Rotavapor (Büchi Labortechnik, Essen, Germany) and the 
volume of the formulations was reduced to 6  mL26. The nanoemulsions were prepared using the same procedure 
but without including chitosan.
A Zetasizer NanoZS (Malvern Instruments, Malvern, UK) fitted with a red laser (λ = 632.8 nm) was used to 
measure the size and ζ-potential of the  nanoformulations25. Diameter of the Chi-NCs was verified by nanoparticle 
tracking analysis (NanoSight LM10, NanoSight, UK). The concentration of free (non-cell bound) fluorescent 
Chi-NCs was determined by tracking the DiO-loaded nanoparticles on an Axiovert 200 fluorescence microscope 
(Zeiss, Oberkochen, Germany) equipped with a 40 × oil objective with a numerical aperture of 1.4 (Zeiss) as 
previously  described73. Images of 256 × 256 pixels were recorded using a water-cooled iXon3 camera (Andor 
Technology, Belfast, UK) at a rate of 10 frames per second and an EMCCD gain of 300. Number of cell bound 
Chi-NCs was calculated by subtracting the number of free Chi-NCs from the total number of Chi-NCs.
Stimulated emission depletion microscopy. Stimulated emission depletion microscopy and confocal 
microscopy were carried out in sequential line scanning mode using an Abberior stimulated emission depletion 
expert line microscope as previously  reported74. Briefly, cells were seeded on glass coverslips and cultivated until 
they reached confluency. After fixation of the cells with 2% paraformaldehyde (Electron Microscopy Sciences) 
in HEPES buffered Ringer’s solution, cell surface glycans were stained with WGA (Sigma-Aldrich) conjugated 
with an ATTO 646 N protein labelling kit (JenaBioscience, Jena, Germany). The stimulated emission depletion 
microscopy setup was based on a Nikon Ti-E microscope body for the excitation and detection of the fluores-
cence signal through a 60 × (numerical aperture 1.4) P-Apo oil immersion objective. A pulsed laser was used for 
excitation at 640 nm and a near-infrared pulsed laser (775 nm) for depletion. The detected signal was directed 
through a variable-sized pinhole (set to match 1 Airy at 640 nm) and detected using novel state-of-the-art ava-
lanche photodiode APDs with appropriate filter settings for Cy5 (615–755 nm). Images were recorded with a 
dwell time of 3 µs, and the voxel size was set to 20 × 20 × 150 nm. Images were acquired in time-gating mode with 
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a gating width of 8 ns and a delay of 781 ps. Glycan clusters on the cell surface were analysed by imageJ software 
and the density of clusters were calculated similar as previously  published48.
Flow cytometry. Cells were collected and incubated with Alexa Fluor 488-conjugated WGA (Thermo 
Fisher Scientific, Waltham, USA, 1:1000) or with the against heparan sulphate directed antibody (10E4 epitope, 
AMS Biotechnology, Frankfurt, Germany; 1:400) for 30  min on ice. After washing with phosphate buffered 
saline (PBS), heparan sulphate antibodies were labelled by Alexa Fluor 488 goat anti-mouse IgM secondary 
antibodies (Thermo Fischer Scientific); 1:1000) for 30  min on ice. PBS washed cells were analysed by a BD 
FACSCanto flow cytometer (Biosciences, Erembodegem, Belgium). For Chi-NC binding experiments cells were 
collected and distributed into tubes (400,000 cells per tube in 600 µL PBS) and Chi-NCs were added at different 
concentrations. The cells were exposed to 1.78 × 1012 Chi-NCs  mL−1 in the experiments shown in Fig. 3d,e, 6b 
and Supplementary Fig. S1, to 8.96 × 1011 Chi-NCs  mL−1 in the experiments shown in Fig. 6c,d, to 4.97 × 1010, 
7.46 × 1010, 1.12 × 1011, 1.68 × 1011, 2.52 × 1011, 3.78 × 1011, 5.66 × 1011, 8.48 × 1011, 1.27 × 1012 Chi-NCs  mL−1 
shown in the experiments in Fig. 7b and to 1.12 × 1011, 2.24 × 1011, 4.48 × 1011, 8.96 × 1011, 1.78 × 1012 Chi-NCs 
 mL−1 in the experiments shown in Fig. 7a and S9. The mixtures were incubated for 30 min on ice and shaken 
approximately five times during incubation. At the end of the incubation period, the mixtures were centrifuged 
at 260×g for 5 min, before removing the supernatant and resuspending the cells in 500 µL PBS. Chi-NC bind-
ing was studied in tubes containing ~ 200,000 cells by detecting the fluorescent dye DiO with the corresponding 
detector of a BD FACSCanto flow cytometer (Biosciences). Prior to flow cytometry, Chi-NC binding to the cell 
surface was verified by fluorescence microscopy.
Flow cytometry after enzyme treatment. T24 cells were detached and treated in the incubator at 37 °C 
with 500 mU mL−1 heparinase I and II (Sigma-Aldrich) in 0.1% bovine serum albumin (BSA), 150 mg mL−1 hya-
luronidase (Sigma-Aldrich) in 0.1% BSA buffer, 500 mU mL−1 chrondroitinase ABC (AMS Biotechnology) in 
0.1% BSA or only in 0.1% BSA as a control for 3 h. The cells were then centrifuged at 260×g for 5 min and washed 
with PBS. The cells were exposed to 8.96 × 1011 Chi-NCs  mL−1.
ECIS. The impedance of UROtsa and T24 cells was measured as previously  described75, using an ECIS 16-well 
station and 8W10E + PET eight-well ECIS slides (both from Applied Biophysics, New York, USA). The ECIS 
slides were coated with 200 µL gelatin (0.5% w/v) for 30 min and stabilised with 200 µL equilibrated RPMI-1640 
medium. UROtsa and T24 cells were seeded into the eight-well plate at a density of 150,000 cells/well in 600 µL 
RPMI-1640 medium (without FCS but containing 1% l-glutamine and 1% penicillin/streptomycin). The imped-
ance was measured continuously at different frequencies (500–64,000 Hz) for 95 h. After 40 h, the RPMI-1604 
medium was refreshed. After 72 h, the Chi-NC treatment solution (dissolved in 100 µL RPMI-1640 medium) 
was added to the wells, directly into the medium without stopping the measurement or removing the slides 
from the incubator. Both cell lines were treated with three concentrations of encapsulated capsaicin (125, 250, 
500 µm) or equivalent quantities of empty Chi-NCs without capsaicin (1.4 × 1012, 2.8 × 1012, 5.6 × 1012 particles 
 mL−1) for control experiments. The impedance measurement was continued for 24 h.
Cell surface charge measurements. The ζ-potential of the UROtsa and T24 cells was measured as pre-
viously  described26. Cells were cultivated until they reached 90% confluency, detached with trypsin and resus-
pended at a concentration of 100,000 cells  mL−1 in isotonic, salt-free 30 mM HEPES buffer supplemented with 
300 mM sucrose (pH 7.4) and containing different volume fractions of Chi-NCs. The ζ-potential was measured 
by mixed laser Doppler velocimetry and phase analysis light scattering (M3-PALS). Particle size and derived 
count rate were determined by dynamic light scattering with non-invasive back scattering (DLS-NIBS) at a 
measurement angle of 173°. The autocorrelation functions were matched to the default non-negative least 
squares (NNLS) fit to calculate the intensity size distribution plots and thus evaluate the Z-average diameter. A 
Malvern Zetasizer NanoZS fitted with a red laser (λ = 632.8 nm) was used for both methods and Zetasizer v7.12 
was used to acquire and evaluate the data.
Structured illumination microscopy of cells treated with fluorescent Chi‑NCs. UROtsa cells or 
T24 cells were seeded on glass coverslips until they formed a confluent layer. Cells were treated with DiO-loaded 
Chi-NCs (2.8 × 1012 particles  mL−1), in RPMI-1640 without FCS for 2 or 24 h. After two washing steps with 
HEPES buffered Ringer’s solution, the cells were fixed with 4% paraformaldehyde (Electron Microscopy Sci-
ences). Cell surfaces were stained with Texas-red-conjugated WGA (Thermo Fisher) diluted in HEPES buffered 
Ringer’s solution (1:1000); nuclei were stained with 4′,6-diamidino-2-phenylindole. After three further washing 
steps, coverslips were embedded into a 1,4-Diazabicyclo-(2,2,2)octan/Mowiol (Sigma Aldrich) and mounted on 
a glass object slide. Samples were imaged using an Observer z1 inverted microscope equipped with a structured 
illumination module (ApoTome, Zeiss). Images were analysed with Zen software (version 1.1.2.0, Zeiss).
Live cell microscopy. T24 and UROtsa cells (150,000 cells/well) were seeded into a chambered microscope 
slide with eight wells (Ibidi, Gräfelfing, Germany) and maintained at 37 °C in a humid, 5%  CO2 atmosphere. Cells 
were imaged by time-lapse phase-contrast and fluorescence microscopy using an Observer z1 inverted micro-
scope at 37 °C and 5%  CO2 in a humidified incubation chamber. Cells were treated with different concentrations 
of nanoencapsulated capsaicin (125 µm capsaicin = 1.4 × 1012 particles  mL−1, 250 µm capsaicin = 2.8 × 1012 parti-
cles  mL−1, 500 µm capsaicin = 5.6 × 1012 particles  mL−1) or the equivalent quantities of Chi-NCs without capsai-
cin. Images were captured every 5 min for 10 h (Fig. 4b-e and Supplementary Video S1 and S2) or every 10 s for 
10 min (Fig. 4f and Supplementary Video S3). ImageJ v1.52 was used to quantify the dynamics of the cell layer. 
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The applied imageJ macro for automatized image analysis was self-made and can be obtained from the authors 
upon request. Briefly, phase-contrast images (8-bit format) were converted into a binary image that shows bright 
regions above a critical threshold in black and regions below a critical threshold value in white. Threshold val-
ues were set automatically using the “mean dark” threshold setting. From consecutive binary images, standard 
deviation was calculated using the imageJ “Z project”. Standard deviation images of one experiment were stacked 
together and mean brightness of every image was calculated. Change of the mean brightness was considered to 
be proportional with the migratory potential of cells within the cell layer. To analyse the formation of vacuoles, a 
similar approach was used (Fig. 4c and Figure Supplementary S3). Briefly, consecutive fluorescence images were 
loaded into imageJ and areas with specific fluorescence intensity range were defined using the auto threshold 
setting “triangle dark”. The area of vacuoles was determined using the measurement function of imageJ. Data 
were further normalised to the average number of cells per field of view.
Western blot. T24 and UROtsa cells were cultured for 72 h in 24-well plates and then treated with 125 or 
250 µm encapsulated capsaicin (1.4 × 1012 or 2.8 × 1012 particles  mL−1) for 24 h before western blot  analysis76. 
Briefly, proteins were separated in a gradient (4–15%) polyacrylamide gel and transferred to a Transblot Turbo 
nitrocellulose membrane (both from Bio-Rad, München, Germany). Antibodies against pro-caspase-3 (dilu-
tion 1:400) and cleaved caspase-3 (dilution 1:100) were obtained from Cell Signaling Technology (Danvers, 
USA). Horseradish peroxidase-conjugated goat-anti-rabbit IgG (Sigma-Aldrich) was used as secondary anti-
body. Bands were visualised by enhanced chemiluminescence (Curix 60, AGFA Healthcare, Bonn, Germany) 
on X-ray films.
Statistical analysis. Results are expressed as mean ± SD. Student’s t-test was used to test for significant dif-
ferences between the cell lines. P values below 0.05 were considered statistically significant.
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